ALISA WANG: Open Payments
NPI 1396968152 · ALISO VIEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,707 in 66 payments from 20 companies in 2025. Trend: 2023 $2,330 · 2024 $2,797 · 2025 $2,707
Food & beverage: $2,698Travel & lodging: $9
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $413 |
| PFIZER INC. | 10 | $381 |
| Amgen Inc. | 7 | $251 |
| Lilly USA, LLC | 8 | $220 |
| Janssen Biotech, Inc. | 3 | $209 |
| Galderma Laboratories, L.P. | 1 | $196 |
| Incyte Corporation | 10 | $194 |
| E.R. Squibb & Sons, L.L.C. | 1 | $137 |
| Janssen Scientific Affairs, LLC | 1 | $126 |
| Arcutis Biotherapeutics, Inc. | 1 | $105 |
Products named: DUPIXENT, TREMFYA, CIBINQO, Otezla, NEMLUVIO, OPZELURA, Sotyktu, EBGLYSS.
Industry payments across CA — which companies pay providers there.
